CG

Caroline Gaynor

Director at Amber Therapeutics

Ireland

Overview

Work Experience

AT

Amber Therapeutics

  • Director

    2024 - Current

VM

Volta Medical

  • Director

    2024

F

FIRE1

  • Director

    2023

LV

Lightstone Ventures

  • Partner

    2023

  • Principal

    2020 - 2023

  • Vice President

    2016 - 2020

P

ProVerum

  • Director

    2022

PT

Parvalis Tx

  • Director

    2021

CB

Catamaran Bio

  • Director

    2020

Situla Consultants Ltd.

  • Director

    2014 - 2020

Education

Investments

Amber Therapeutics

Series A

Total Funding: $100M

ProVerum Medical

Series A

Total Funding: $34M

Catamaran Bio

Series A

Total Funding: $47M

Relevant Websites